Back
 Health  Vol.8 No.13 , October 2016
Impact of a Dietary Supplement Containing Rosemary and Daylily on Biochemical Markers of Cognitive Health, Sleep Quality and Related Variables in Men and Women
Abstract: Background: We investigated the influence of a botanical agent to improve sleep quality and associated measures in men and women with self-reported difficulty sleeping. Methods: 32 individuals were randomly assigned in double blind manner to ingest a botanical agent (CLOCK?, containing Rosemary [Rosmarinus officinalis] and Daylily [Hemerocallis fulva]) or a placebo over a 6-week intervention. During weeks 1 and 2, subjects ingested one serving of the assigned condition, followed by a two-week washout. During weeks 5 and 6, subjects ingested two servings of the condition. The Leeds Sleep Evaluation Questionnaire was used as an outcome measure, as were subjective measures of sleep quality, energy level, and mood. Blood samples collected pre- and post-intervention were assayed for acetylcholine (ACH), brain-derived neurotrophic factor (BDNF), irisin, and melatonin. Results: No differences were noted between conditions in measures of sleep (p > 0.05). While no differences of statistical significance were noted in subjective feelings, during weeks 5 and 6 as compared to baseline, subjects assigned to the supplement noted an 8% increase in attentiveness, an 11% increase in alertness, a 12% increase in focus, a 14% increase in feeling energetic, a 12% increase in enthusiasm, a 23% increase in feeling well rested, an 11% decrease in feeling sluggish, and a 16% decrease in feeling depressed, without the same improvement observed for subjects in the placebo group. All biochemical measures were increased from pre- to post-treatment with two servings of the supplement; the largest percent increase noted for BDNF (27%) and the largest effect size noted for irisin (d = 1.36). Biochemical values for the placebo condition were unchanged. Conclusions: CLOCK? may have an impact on certain measurements of mood, with a significant impact on the biochemical marker, BDNF. Future studies using a larger sample size and perhaps a cross-over design may help to further clarify the impact of this dietary supplement on aspects of sleep quality, mood, and other related variables.
Cite this paper: Bloomer, R. , MacDonnchadh, J. , Moran, R. , Timmcke, J. and Qin, B. (2016) Impact of a Dietary Supplement Containing Rosemary and Daylily on Biochemical Markers of Cognitive Health, Sleep Quality and Related Variables in Men and Women. Health, 8, 1307-1322. doi: 10.4236/health.2016.813132.
References

[1]   Institute of Medicine (2006) Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. The National Academies Press, Washington DC.

[2]   Chong, Y., Fryer, C.D. and Gu, Q. (2013) Prescription Sleep Aid Use among Adults: United States, 2005-2010. NCHS Data Brief, 127, 1-8.

[3]   Turek, F.W. and Gillette, M.U. (2004) Melatonin, Sleep, and Circadian Rhythms: Rationale for Development of Specific Melatonin Agonists. Sleep Medicine, 5, 523-532.
http://dx.doi.org/10.1016/j.sleep.2004.07.009

[4]   Al-Sereitia, M., Abu-Amerb, K. and Sena, P. (1999) Pharmacology of Rosemary (Rosmarinus officinialis Linn.) and Its Therapeutic Potentials. Indian Journal of Experimental Biology, 37, 124-131.

[5]   Erkan, N., Ayranci, G. and Ayranci, E. (2008) Antioxidant Activities of Rosemary (Rosmarinus officinalis L.) Extract, Blackseed (Nigella sativa L.) Essential Oil, Carnosic Acid, Rosmarinic Acid and Sesamol. Food Chemistry, 110, 76-82.
http://dx.doi.org/10.1016/j.foodchem.2008.01.058

[6]   Tai, J., Cheung, S., Wu, M. and Hasman, D. (2012) Antiproliferation Effect of Rosemary (Rosmarinus officinalis) on Human Ovarian Cancer Cells in Vitro. Phytomed, 19, 436-443.
http://dx.doi.org/10.1016/j.phymed.2011.12.012

[7]   Foster, S. and Johnson, R.L. (2006) Rosemary. In: National Geographic Desk Reference to Natural Medicine. National Geographic Society Publisher, Washington DC, 316.

[8]   Machado, D.G., Cunha, M.P., Neis, V.B, Balen, G.O., Colla, A.R. and Grando, J. (2012) Rosmarinus officinalis L. Hydroalcoholic Extract, Similar to Fluoxetine, Reverses Depressive-Like Behavior without Altering Learning Deficit in Olfactory Bulbectomized Mice. Journal of Ethnopharmacology, 143, 158-169.
http://dx.doi.org/10.1016/j.jep.2012.06.017

[9]   Machado, D.G., Bettio, L.E., Cunha, M.P., Capra, J.C., Dalmarco, J.B. and Pizzolatti, M.G. (2009) Antidepressant-Like Effect of the Extract of Rosmarinus officinalis in Mice: Involvement of the Monoaminergic System. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33, 642-650.
http://dx.doi.org/10.1016/j.pnpbp.2009.03.004

[10]   Solhi, H., Salehi, B., Alimoradian, A., Pazouki, S., Taghizadeh, M. and Saleh, A.M. (2013) Beneficial Effects of Rosmarinus officinalis for Treatment of Opium Withdrawal Syndrome during Addiction Treatment Programs: A Clinical Trial. Addict Health, 5, 90.

[11]   Zhang, Y., Cichewicz, R.H. and Nair, M.G. (2004) Lipid Peroxidation Inhibitory Compounds from Daylily (Hemerocallis fulva) Leaves. Life Science, 75, 753-763.
http://dx.doi.org/10.1016/j.lfs.2004.03.002

[12]   Cichewicz, R.H., Zhang, Y., Seeram, N.P. and Nair, M.G. (2004) Inhibition of Human Tumor Cell Proliferation by Novel Anthraquinones from Daylilies. Life Science, 74, 1791-1799.
http://dx.doi.org/10.1016/j.lfs.2003.08.034

[13]   Uezu, E. (1998) Effects of Hemerocallis on Sleep in Mice. Psychiatry and Clinical Neurosciences, 52, 136-137.
http://dx.doi.org/10.1111/j.1440-1819.1998.tb00992.x

[14]   Lin, S.H., Chang, H.C., Chen, P.J., Hsieh, C.L., Su, K.P. and Sheen, L.Y. (2013) The Anti-depressant-Like Effect of Ethanol Extract of Daylily Flowers in Rats. Journal of Alternative and Complementary Medicine, 3, 53.
http://dx.doi.org/10.4103/2225-4110.106548

[15]   Qin, B., Shea-Donohue, T., Liu, C., Quilici Timmcke, J. and Anderson, R.A. (2016) The Regulation in Key Protein Expression Related to Circadian Rhythms with a Natural Compound Containing Rosemary and Hemerocallis fulva Extract in Vitro. FASEB Journal, 30, No. 1.
http://dx.doi.org/10.1096/fj.1530-6860

[16]   Morin, C.M, Belleville, G., Bélanger, L. and Ivers, H. (2011) The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment Response. Sleep, 34, 601-608.

[17]   Tishler, P.V., Larkin, E.K., Schluchter, M.D. and Redline, S. (2003) Incidence of Sleep-Disordered Breathing in an Urban Adult Population: The Relative Importance of Risk Factors in the Development of Sleep-Disordered Breathing. JAMA, 289, 2230-2237.
http://dx.doi.org/10.1001/jama.289.17.2230

[18]   Parrott, A.C. and Hindmarch, I. (1980) The Leeds Sleep Evaluation Questionnaire in Psychopharmacological Investigations: A Review. Psychopharmacology, 71, 173-179.
http://dx.doi.org/10.1007/BF00434408

[19]   Donnelly, G.F. (2004) The Placebo Effect and Holistic Interventions. Holistic Nursing Practice, 18, 238-241.
http://dx.doi.org/10.1097/00004650-200409000-00006

[20]   Eccles, R. (2007) The Power of the Placebo. Current Allergy and Asthma Reports, 7, 100- 104.
http://dx.doi.org/10.1007/s11882-007-0006-2

[21]   Finniss, D.G., Kaptchuk, T.J., Miller, F. and Benedetti, F. (2010) Biological, Clinical, and Ethical Advances of Placebo Effects. Lancet, 375, 686-695.
http://dx.doi.org/10.1016/S0140-6736(09)61706-2

[22]   Cornu, C., Remontet, L., Noel-Baron, F., Nicolas, A., Feugier-Favier, N., Roy, P. and Claustrat, B. (2010) A Dietary Supplement to Improve the Quality of Sleep: A Randomized Placebo Controlled Trial. BMC Complementary and Alternative Medicine, 10, 29.
http://dx.doi.org/10.1186/1472-6882-10-29

[23]   Paul, I.M., Yoder, K.E., Crowell, K.R., Shaffer, M.L., McMillan, H.S. and Carlson, L.C. (2004) Effect of Dextromethorphan, Diphenhydramine, and Placebo on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. Pediatrics, 114, e85-e90.
http://dx.doi.org/10.1542/peds.114.1.e85

[24]   Mayberg, H.S., Silva, J.A., Brannan, S.K., Tekell, J.L., Mahurin, R.K. and McGinnis, S. (2002) The Functional Neuroanatomy of the Placebo Effect. American Journal of Psychiatry, 159, 728-737.
http://dx.doi.org/10.1176/appi.ajp.159.5.728

[25]   Ferris, L.T., Williams, J.S. and Shen, C.L. (2007) The Effect of Acute Exercise on Serum Brain-Derived Neurotrophic Factor Levels and Cognitive Function. Medicine & Science in Sports & Exercise, 39, 728-734.
http://dx.doi.org/10.1249/mss.0b013e31802f04c7

[26]   Hashimoto, K., Shimizu, E. and Iyo, M. (2004) Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders. Brain Research Reviews, 45, 104-114.
http://dx.doi.org/10.1016/j.brainresrev.2004.02.003

[27]   Komulainen, P., Pedersen, M., Hanninen, T., Bruunsgaard, H., Lakka, T.A. and Kivipelto, M. (2008) BDNF Is a Novel Marker of Cognitive Function in Ageing Women: The DR’s EXTRA Study. Neurobiology of Learning and Memory, 90, 596-603.
http://dx.doi.org/10.1016/j.nlm.2008.07.014

[28]   Mikoteit, T., Hemmeter, U., Eckert, A., Brand, S., Bischof, R. and Delini-Stula, A. (2015) Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression. Neuropsychobiology, 72, 16-28.
http://dx.doi.org/10.1159/000437439

[29]   Tsuchiya, Y., Ando, D., Takamatsu, K. and Goto, K. (2015) Resistance Exercise Induces a Greater Iris in Response than Endurance Exercise. Metabolism, 64, 1042-1050.
http://dx.doi.org/10.1016/j.metabol.2015.05.010

[30]   McClung, C.A. (2013) How Might Circadian Rhythms Control Mood? Let Me Count the Ways. Biological Psychiatry, 74, 242-249.
http://dx.doi.org/10.1016/j.biopsych.2013.02.019

[31]   Wirz-Justice, A. (2006) Biological Rhythm Disturbances in Mood Disorders. International Clinical Psychopharmacology, 21, S11-S15.
http://dx.doi.org/10.1097/01.yic.0000195660.37267.cf

[32]   Kohyama, J. and Frank, M.G. (2016) Neural Basis of Brain Dysfunction Produced by Early Sleep Problems. Brain Sciences, 6, 5.
http://dx.doi.org/10.3390/brainsci6010005

 
 
Top